In another 36-week, randomized, double-blind, multi-centre, flexible-dose trial, blood lowering effect of dried aqueous extract of the heartwood of P. marsupium was compared with that of Tolbutamide, in newly-diagnosed or untreated type 2 diabetic subjects. Subjects were randomly divided into Pterocarpus extract group (n=172) and Tolbutamide group (n=177) and were treated with increasing dosage (i.e Pterocarpus extract: 2 g, 3 g and 4 g/day and Tolbutamide: 0.75 g, 1 g, and 1.5 g/day) at a gap of 4 weeks each. Results demonstrated that supplementation with Pterocarpus extract was able to lower blood glucose levels in 86% subjects, which was comparable to Tolbutamide efficacy (i.e. 94%). Hence, it was concluded that Pterocarpus extract could be an effective blood glucose lowering agent in type 2 diabetes without any significant side effects (Diabetologia Croatica, 2005).
Blood Glucose Levels (mmol/L) | ||||
---|---|---|---|---|
Parameter | Drug Group | At baseline | At 36 weeks | |
Fasting | Pterocarpus extract (n=172) | 9.4 | 7.0 | |
Tolbutamide (n=177) | 9.4 | 6.7 | ||
Postprandial | Pterocarpus extract (n=172) | 13.9 | 9.6 | |
Tolbutamide (n=177) | 13.8 | 9.4 |
Sabinsa does not have a legal binding obligation for the information mentioned in this document, or further answers/information provided thereof. The data and information contained herein are believed to be accurate presented in good faith only for your guidance. Sabinsa recommends that further tests be conducted accordingly to the suitability of the product for specific application/use. Our customers are open to perform a full inspection of the products upon delivery or any other obligation. Sabinsa does not provide any warranties of any kind regarding the products described or designs, data or information set forth, or the use of the products, designs, data or information without infringing the intellectual property rights of others. Under no circumstances the information, data or designs provided shall be considered a part of our terms and conditions of sale.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure,or prevent any disease. Health claims are not evaluated and approved by EFSA as per EC regulation 1924/2006. FAQ_02.